KORRO BIO INC (KRRO)

US5009461089 - Common Stock

54.66  +3.4 (+6.63%)

After market: 54.66 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.0014.07M36.98M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
85.48M84.53M83.00M98.10M64.53M
Research and Development
59.46M57.25M49.42M60.92M37.42M
Selling, General, and Administrative Expenses
26.02M27.28M33.58M37.18M27.12M
Operating Income
-85.48M-84.53M-83.00M-84.03M-27.55M
Interest Income/Expense
N/AN/A364.00K-374.00K1.07M
Other Income/Expense
4.55M3.39M1.06M-266.00KN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-81.16M-81.14M-81.58M-84.67M-26.48M
Income Tax
22.00K27.00K-2.00K15.00K40.00K
Net Income
-81.19M-81.17M-81.58M-84.69M-26.51M
EBITDA
-82.12M-80.90M-80.24M-81.26M-26.40M
 
Per Share Data
EPS Diluted Total Ops
-43.03-53.08-116.29-123.26-0.82
Non GAAP EPS
N/A-83.65-116.00-2.47-0.81
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/A-601.98%-71.69%
Operating Profit Margin
N/AN/AN/A-597.32%-74.50%

All data in USD

Charts